Department of Orthopaedic Surgery, Boston University, Boston, MA.
J Orthop Trauma. 2019 Dec;33(12):e447-e451. doi: 10.1097/BOT.0000000000001594.
To determine whether a continuous femoral nerve block after open reduction internal fixation of tibial plateau fractures would diminish Visual Analog Scale (VAS) scores and/or systemic narcotic intake.
Randomized controlled trial.
Level 1 academic trauma center.
Forty-two consecutive patients with operatively treated tibial plateau fractures.
Continuous femoral nerve catheter for postoperative pain management was performed in the experimental group.
Both the VAS scores for pain and narcotic intake were assessed at 4, 8, 12, 24, 36, 48, and 72 hours postoperatively.
Forty-two patients were enrolled in this study. There were 21 women and 21 men 21-70 years of age (avg 49) with operatively treated tibial plateau fractures. Twenty-one patients were randomized to receive a femoral nerve block with 5 crossovers for technical reasons. Accordingly, we analyzed 16 patients with femoral nerve blocks and 26 with standard care. There were no significant differences between the study groups regarding age, sex, or fracture type. There was no significant difference in VAS scores between the control and experimental group at any time point. The total systemic morphine equivalent for the femoral nerve block group and the control group was 375 and 397 respectively (P = 0.76). Across groups, patients with bicondylar fractures tended to have higher VAS than those with unicondylar fractures and to use more narcotics, although neither was statistically significant.
Femoral nerve blocks for postoperative pain management in tibial plateau fractures did not demonstrate an improvement in pain relief or narcotic use.
Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
确定胫骨平台骨折切开复位内固定术后行股神经持续阻滞是否会降低视觉模拟评分(VAS)和/或全身阿片类药物的摄入量。
随机对照试验。
1 级学术创伤中心。
42 例连续接受手术治疗的胫骨平台骨折患者。
实验组行股神经导管用于术后疼痛管理。
术后 4、8、12、24、36、48 和 72 小时分别评估 VAS 疼痛评分和阿片类药物摄入量。
本研究共纳入 42 例患者,其中女性 21 例,男性 21-70 岁(平均年龄 49 岁),均为手术治疗的胫骨平台骨折患者。21 例患者因技术原因随机接受股神经阻滞 5 次。因此,我们分析了 16 例接受股神经阻滞的患者和 26 例接受标准治疗的患者。研究组在年龄、性别或骨折类型方面无显著差异。在任何时间点,对照组和实验组的 VAS 评分均无显著差异。股神经阻滞组和对照组的全身吗啡等效剂量分别为 375 和 397(P = 0.76)。在两组患者中,双髁骨折患者的 VAS 评分均高于单髁骨折患者,且使用的阿片类药物也更多,但均无统计学意义。
胫骨平台骨折术后行股神经阻滞用于疼痛管理并未显示在缓解疼痛或减少阿片类药物使用方面的优势。
治疗学 1 级。请参阅作者指南以获取完整的证据等级描述。